Model of insulin's influence on amyloid β

By Kerry Grens LITERATUREARTICLE EXTRASRelated ArticleAlzheimer's: Type 3 Diabetes?Channel CandidatesA Channel at LargeThe Inner Workings of Hearing MachineryCracking Open a New Channel FamilyFacelessness, facedThe singing earBaby brain bankOpening Potassium Channels to ScrutinyDownstream of insulin signaling are links to amyloid β (Aβ), the principle peptide that forms the plaqu

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

LITERATURE

Related Article

Alzheimer's: Type 3 Diabetes?

Channel Candidates

A Channel at Large

The Inner Workings of Hearing Machinery

Cracking Open a New Channel Family

Facelessness, faced

The singing ear

Baby brain bank

Opening Potassium Channels to Scrutiny

Downstream of insulin signaling are links to amyloid β (Aβ), the principle peptide that forms the plaques in brains of patients with Alzheimer's disease. It begins with insulin receptor activation turning on the phosphoinositide kinase, PI3K, which generates the lipid messenger, PIP3. PIP3 activates the signaling protein AKT (serine/threonine kinase).

AKT can affect Aβ in two ways. One is that AKT mediates the upregulation of insulin degrading enzyme, IDE, which not only breaks down insulin, but is also thought to degrade Aβ. Conversely, AKT restricts GSK3β, a kinase thought to be involved in stimulating Aβ production. The activation of either pathway can therefore reduce Aβ levels, either by degrading the peptide or ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies